CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024		5,511,452
Beginning balance at Dec. 31, 2024	$ 188,533	$ 6	$ 489,409	$ (356,976)	$ 56,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		1,161
Common stock issued for Employee Stock Purchase Plan	40		40
Stock-based compensation (in shares)		422,091
Stock-based compensation	23,252		23,252
Vesting of Restricted Stock Units (in shares)		15,835
Distributions	(7,364)				(7,364)
Net income (loss)	50,806			21,217	29,589
End balance (in shares) at Mar. 31, 2025		5,950,539
Ending balance at Mar. 31, 2025	255,267	$ 6	512,701	(335,759)	78,319
Beginning balance (in shares) at Dec. 31, 2025		7,086,670
Beginning balance at Dec. 31, 2025	423,437	$ 7	615,627	(286,187)	93,990
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		547
Common stock issued for Employee Stock Purchase Plan	97		97
Stock-based compensation (in shares)		12,753
Stock-based compensation	1,604		1,604
Vesting of Restricted Stock Units (in shares)		52,096
Distributions	$ (15,357)				(15,357)
Stock repurchases and retirements (in shares)	(200,444)	(200,444)
Stock repurchases and retirements	$ (31,730)		(31,730)
Contributions	1,239		68		1,171
Net income (loss)	62,763			46,807	15,956
End balance (in shares) at Mar. 31, 2026		6,951,622
Ending balance at Mar. 31, 2026	$ 442,053	$ 7	$ 585,666	$ (239,380)	$ 95,760